Submitted:
31 May 2024
Posted:
04 June 2024
You are already at the latest version
Abstract

Keywords:
1. Introduction
2. Results and Discussion
2.1. General Approaches and Targets
2.2. Syntheses of TSCs
2.2.1. Thiosemicarbazones Derived from Amino Acids
2.2.2. Thiosemicarbazones Derived from Diamines
2.2.3. Thiosemicarbazones Derived from Acetobromo-α-D-Glucose
2.2.4. Thiosemicarbazones with a Hydroxy-Alkyl Function
2.2.5. Thiosemicarbazones with a o-Hydroquinone Function
2.2.6. Thiosemicarbazones Derived from Amino Thiols
2.2.7. Thiosemicarbazones with an Alkyne Function
2.2.8. Attempted Synthesis of Thiosemicarbazones with a Bromide Function
2.2.9. Thiosemicarbazones with an Azide Function
2.2.10. Thiosemicarbazones with a Phosphonate Group
2.2.11. Attempted Synthesis of Thiosemicarbazones with a Silane Group
3. Materials and Methods
3.1. Materials and Synthesis
3.2. Instrumentation
4. Conclusions and Outlook
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Sample Availability
References
- McNamara, W.R.; Snoeberger, R.C.; Li, G.; Schleicher, J.M.; Cady, C.W.; Poyatos, M.; Schmuttenmaer, C.A.; Crabtree, R.H.; Brudvig, G.W.; Batista, V.S. Acetylacetonate Anchors for Robust Functionalization of TiO2 Nanoparticles with Mn(II)−Terpyridine Complexes. J. Am. Chem. Soc. 2008, 130, 14329–14338. [CrossRef]
- Neouze, M.; Schubert, U. Surface Modification and Functionalization of Metal and Metal Oxide Nanoparticles by Organic Ligands. Monatsh. Chem. 2008, 139, 183–195. [CrossRef]
- Vigderman, L.; Zubarev, E.R. Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules. Adv. Drug Deliv. Rev. 2013, 65 (5), 663–676. [CrossRef]
- Kumar, R.; Roy, I.; Ohulchanskyy, T.Y.; Goswami, L.N.; Bonoiu, A.C.; Bergey, E.J.; Tramposch, K.M.; Maitra, A.; Prasad, P.N. Covalently Dye-Linked, Surface-Controlled, and Bioconjugated Organically Modified Silica Nanoparticles as Targeted Probes for Optical Imaging. ACS Nano 2008, 2, 449–456. [CrossRef]
- Verma, G.; Shetake, N.G.; Barick, K.C.; Pandey, B.N.; Hassan, P.A.; Priyadarsini, K.I. Covalent immobilization of doxorubicin in glycine functionalized hydroxyapatite nanoparticles for pH-responsive release. New J. Chem. 2018, 42, 6283–6292. [CrossRef]
- Latorre, A.; Couleaud, P.; Aires, A.; Cortajarena, A.L.; Somoza, A. Multifunctionalization of magnetic nanoparticles for controlled drug release: A general approach. Eur. J. Med. Chem. 2014, 82, 355–362. [CrossRef]
- Gisbert-Garzarán, M.; Manzano, M.; Vallet-Regí, M. Multifunctionalization of magnetic nanoparticles for controlled drug release: A general approach pH-Responsive Mesoporous Silica and Carbon Nanoparticles for Drug Delivery. Bioengineering 2017, 4 (1), 3. [CrossRef]
- Choy, C.J.; Geruntho, J.J.; Davis, A.L.; Berkman, C.E. Tunable pH-Sensitive Linker for Controlled Release. Bioconjugate Chem. 2016, 27, 824−830. [CrossRef]
- Amstad, E.; Textor, M.; Reimhult, E. Stabilization and functionalization of iron oxide nanoparticles for biomedical applications. Nanoscale 2011, 3, 2819–2843. [CrossRef]
- Gambinossi, F.; Mylon, S.E.; Ferri, J.K. Aggregation kinetics and colloidal stability of functionalized nanoparticles. Adv. Colloid Interface Sci. 2015, 222, 332-349. [CrossRef]
- Burger, A.; Srikantharajah, R.; Peukert, W.; Hirsch, A. Individualization and Stabilization of Zinc Oxide Nanorods by Covalent Functionalization with Positively Charged Catechol Derivatives. Chem.–Eur. J. 2017, 23, 17257–17268. [CrossRef]
- Wen, J.; Yang, K.; Liu, F.; Li, H.; Xu, Y.; Sun, S. Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems. Chem. Soc. Rev. 2017, 46, 6024-6045. [CrossRef]
- Xue, Y.; Bai, H.; Peng, B.; Fang, B.; Baell, J.; Li, L.; Huang, W.; Voelcker, N.H. Stimulus-cleavable chemistry in the field of controlled drug delivery. Chem. Soc. Rev. 2021, 50, 4872-4931. [CrossRef]
- Dal Corso, A.; Pignataro, L.; Belvisi, L.; Gennari, C. Innovative Linker Strategies for Tumor-Targeted Drug Conjugates. Chem.–Eur. J. 2019, 25, 14740–14757. [CrossRef]
- Yang, X.; Pan, Z.; Choudhury, M.R.; Yuan, Z.; Anifowose, A.; Yu, B.; Wang, W.; Wang, B. Making smart drugs smarter: The importance of linker chemistry in targeted drug delivery. Med. Res. Rev. 2020, 40, 2682–2713. [CrossRef]
- Yan, Y.; Ding, H. pH-Responsive Nanoparticles for Cancer Immunotherapy: A Brief Review. Nanomaterials 2020, 10, 1613. [CrossRef]
- Zheng, H.; Xing, L.; Cao, Y.; Che, S. Coordination bonding based pH-responsive drug delivery systems. Coord. Chem. Rev. 2013, 257, 1933–1944. [CrossRef]
- Novio, F.; Simmchen, J.; Vázquez-Mera, N.; Amorín-Ferré, L.; Ruiz-Molina, D. Coordination polymer nanoparticles in medicine. Coord. Chem. Rev. 2013, 257, 2839–2847. [CrossRef]
- Gessner, I.; Neundorf, I. Nanoparticles Modified with Cell-Penetrating Peptides: Conjugation Mechanisms, Physicochemical Properties, and Application in Cancer Diagnosis and Therapy. Int. J. Mol. Sci. 2020, 21, 2536. [CrossRef]
- Jeong, W.-j.; Bu, J.; Kubiatowicz, L.J.; Chen, S.S.; Kim, Y.S.; Hong. S. Peptide–nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms? Nano Converg. 2018, 5 (38), 1–18. [CrossRef]
- Summers, K.L. A Structural Chemistry Perspective on the Antimalarial Properties of Thiosemicarbazone Metal Complexes. Mini-Rev. Med. Chem. 2019, 19, 569–590. [CrossRef]
- Kalinowski, D.S.; Quach, P.; Richardson, D.R. Thiosemicarbazones: the new wave in cancer treatment. Fut. Med. Chem. 2009, 1, 689-703. [CrossRef]
- Kang, I.-J.; Wang, L.-W.; Hsu, T.-A.; Yueh, Lee, C.C.; Lee, Y.-C.; Lee, C.-Y.; Chao, Y.-S.; Shih, S.-R.; Chern, J.-H. Isatin-β-thiosemicarbazones as potent herpes simplex virus inhibitors. Bioorg. Med. Chem. Lett. 2011, 21, 1948–1952. [CrossRef]
- Fonteh, P.N.; Keter, F.K.; Meyer, D. New bis(thiosemicarbazonate) gold(III) complexes inhibit HIV replication at cytostatic concentrations: Potential for incorporation into virostatic cocktails. J. Inorg. Biochem. 2011, 105, 1173–1180. [CrossRef]
- Bisceglie, F.; Bacci, C.; Vismarra, A.; Barilli, E.; Pioli, M.; Orsoni, N.; Pelosi, G. Antibacterial activity of metal complexes based on cinnamaldehyde thiosemicarbazone analogues. J. Inorg. Biochem. 2020, 203, 110888. [CrossRef]
- Machado, J.F.; Marques, F.; Pinheiro, T.; Brito, M.J.V.; Scalese, G.; Pérez-Díaz, L.; Otero, L.; António, J.P.M.; Gambino, D.; Morais, T.S. Copper(I)-Thiosemicarbazone Complexes with Dual Anticancer and Antiparasitic Activity. ChemMedChem 2023, 18, e202300074. [CrossRef]
- Dilworth, J.R.; Hueting, R. Metal complexes of thiosemicarbazones for imaging and therapy. Inorg. Chim. Acta 2012, 389, 3–15. [CrossRef]
- Jain, P.; Sharma, S.; Kuma, N.; Misra, N. Ni(II) and Cu(II) complexes of bidentate thiosemicarbazone ligand: Synthesis, structural, theoretical, biological studies and molecular modeling. Appl. Organomet. Chem. 2020, 34, e5736. [CrossRef]
- Mathuber, M.; Hager, S.; Keppler, B.K.; Heffeter, P.; Kowol, C.R. Liposomal formulations of anticancer copper(II) thiosemicarbazone complexes. Dalton Trans. 2021, 50, 16053–16066. [CrossRef]
- Fischer, B.; Kryeziu, K.; Kallus, S.; Heffeter, P.; Berger, W.; Kowol, C.R.; Keppler, B.K. Nanoformulations of anticancer thiosemicarbazones to reduce methemoglobin formation and improve anticancer activity. RSC Adv. 2016, 6, 55848–55859. [CrossRef]
- Toan, V.N.; Thanh, N.D.; Tri, N.M.; Huong, N.T.T. Synthesis and biological screening of thiosemicarbazones of substituted 3-acetylcoumarins having d-glucose moiety. Bioorg. Med. Chem. Lett. 2020, 30, 127664. [CrossRef]
- Thanh, N.D.; Duc, H.T.; Duyen, V.T.; Tuong, P.M.; Quoc, N.V. Synthesis and antibacterial and antifungal activities of N-(tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones of substituted 4-formylsydnones. Chem. Cent. J. 2015, 9, 60. [CrossRef]
- Thanh, N.D.; Giang, N.T.K.; Quyen, T.H.; Huong, D.T.; Toan, V.N. Synthesis and evaluation of in vivo antioxidant, in vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones. Eur. J. Med. Chem. 2016, 123, 532-543. [CrossRef]
- Dong, X.; Wang, H.; Zhang, H.; Li, M.; Huang, Z.; Wang, Q.; Li, X. Copper-thiosemicarbazone complexes conjugated-cellulose fibers: Biodegradable materials with antibacterial capacity. Carbohydr. Polym. 2022, 294, 119839. [CrossRef]
- Akam, E.A.; Tomat, E. Targeting Iron in Colon Cancer via Glycoconjugation of Thiosemicarbazone Prochelators. Bioconjugate Chem. 2016, 27 (8), 1807–1812. [CrossRef]
- Milunovic, M.N.M.; Enyedy, É.A.; Nagy, N.V.; Kiss, T.; Trondl, R.; Jakupec, M.A.; Keppler, B.K.; Krachler, R.; Novitchi, G.; Arion, V.B. l- and d-Proline Thiosemicarbazone Conjugates: Coordination Behavior in Solution and the Effect of Copper(II) Coordination on Their Antiproliferative Activity. Inorg. Chem. 2012, 51 (17), 9309–9321. [CrossRef]
- Paterson, B.M.; Karas, J.A.; Scanlon, D.B.; White, J.M.; Donnelly P.S. Versatile New Bis(thiosemicarbazone) Bifunctional Chelators: Synthesis, Conjugation to Bombesin(7−14)-NH2, and Copper-64 Radiolabeling. Inorg. Chem. 2010, 49, 4, 1884–1893. [CrossRef]
- Haseloer, A.; Lützenburg, T.; Strache, J.P.; Neudörfl, J.; Neundorf, I.; Klein, A. Building up PtII−Thiosemicarbazone−Lysine−sC18 Conjugates. ChemBioChem 2021, 22, 694–704. [CrossRef]
- Kallus, S.; Uhlik, L.; Schoonhoven, S.; Pelivan, K.; Berger, W.; Enyedy, E.A.; Hofmann, T.; Heffeter, P.; Kowol, C.R.; Keppler, B.K. Synthesis and biological evaluation of biotin-conjugated anticancer thiosemicarbazones and their iron(III) and copper(II) complexes. J. Inorg. Biochem. 2019, 190, 85–97. [CrossRef]
- Sung, Y.S.; Wu, W.; Ewbank, M.A.; Utterback, R.D.; Marty, M.T.; Tomat, E. Albumin Conjugates of Thiosemicarbazone and Imidazole-2-thione Prochelators: Iron Coordination and Antiproliferative Activity. ChemMedChem 2021, 16, 2764– 2768. [CrossRef]
- Franciscato, D.S.; Matias, T.A.; Shinohara, J.; Gonçalves, J.M.; Coelho, N.P.; Fernandes, C.S.; Basso, E.A.; Nakatani, H.S.; Araki, K.; Toma, H.E.; de Souza, V.R. Thiosemicarbazone@Gold nanoparticle hybrid as selective SERS substrate for Hg2+ ions. Spectrochim. Acta A Mol. Biomol. 2018, 204, 174–179. [CrossRef]
- Ali, I.; Isaac, I.O.; Ahmed, F.; Aslam, F.; Ali, S.; Imran, M.; Alharthy, R.D.; Shah, M.R.; Malik, M.I.; Hameed, A. Acridine-Thiosemicarbazones-Stabilized Silver Nanoparticles as a Selective Sensor for Copper(II)-Ion in Tap Water. ChemistrySelect 2019, 4, 8757–8763. [CrossRef]
- Kaviani, N.; Behrouz, S.; Jafari, A.A.; Rad, M.N.S. Functionalization of Fe3O4@SiO2 nanoparticles with Cu(I)-thiosemicarbazone complex as a robust and efficient heterogeneous nanocatalyst for N-arylation of N-heterocycles with aryl halides. RSC Adv. 2023, 13, 30293–30305. [CrossRef]
- Britta, E.A.; da Silva, C.C.; Rubira, A.F.; Nakamura, C.V.; Borsali, R. Generating nanoparticles containing a new 4-nitrobenzaldehyde thiosemicarbazone compound with antileishmanial activity. Mater. Sci. Eng. C 2016, 69, 1159–1166. [CrossRef]
- Khan, A.A.; Alanazi, A.M.; Alsaif, N.; Algrain, N.; Wani, T.A.; Bhat, M.A. Enhanced Efficacy of Thiosemicarbazone Derivative-Encapsulated Fibrin Liposomes against Candidiasis in Murine Model. Pharmaceutics 2021, 13, 333. [CrossRef]
- Holley, C.K.; Sinquefield, B.; Majd, S. Optimization of the Single Emulsion Method for Encapsulation of a Cancer Drug in Nanoparticles. 2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Berlin, Germany, 2019, 1078–1081. [CrossRef]
- Oliveira, C.G.; Dalmolin, L.F.; Silva, R.T.C.; Lopez, R.F.V.; Maia, P.I.S.; Moreto, J.A. PLGA-nanoparticles loaded with a thiosemicarbazone derived palladium(II) complex as a potential agent to new formulations for human ovarian carcinoma treatment. New J. Chem. 2020, 44, 14928–14935. [CrossRef]
- Spadola, G.; Sanna, V.; Bartoli, J.; Carcelli, M.; Pelosi, G.; Bisceglie, F.; Restivo, F.M.; Degola, D. Rogolino, D. Thiosemicarbazone nano-formulation for the control of Aspergillus flavus. Environ. Sci. Pollut. Res. 2020, 27, 20125–20135. [CrossRef]
- Hernández, W.; Vaisberg, A.J.; Tobar, M.; Álvarez, M.; Manzur, J.; Echevarría, Y.; Spodine, E. In vitro antiproliferative activity of palladium(II) thiosemicarbazone complexes and the corresponding functionalized chitosan coated magnetite nanoparticles. New J. Chem. 2016, 40, 1853–1860. [CrossRef]
- Gholipour, N.; Akhlaghi, M.; Kheirabadi, A.M.; Geramifar, P.; Beiki, D. Development of Ga-68 labeled, biotinylated thiosemicarbazone dextran-coated iron oxide nanoparticles as multimodal PET/MRI probe. Int. J. Biol. Macromol. 2020, 148, 932–941. [CrossRef]
- Shafiei, I.; Tavassoli, S.P.; Rahmatollahi, H.R.; Ghasemian, R.; Salehzadeh, A. A Novel Copper Oxide Nanoparticle Conjugated by Thiosemicarbazone Promote Apoptosis in Human Breast Cancer Cell Line. J. Clust. Sci. 2022, 33, 2697–2706. [CrossRef]
- Badrooh, M.; Shokrollahi, F.; Javan, S.; Ghasemipour, T.; Mojdehi, S.R.; Farahnak, H.; Noveiri, M.J.S.; Hedayati, M.; Salehzadeh, A. Trigger of apoptosis in adenocarcinoma gastric cell line (AGS) by a complex of thiosemicarbazone and copper nanoparticles. Mol. Biol. Rep. 2022, 49, 2217–2226. [CrossRef]
- Habibi, A.; Ataollah, S.; Shandi, S.; Salehzadeh, A.; Moradi-Shoeili, Z. Novel pyridinecarboxaldehyde thiosemicarbazone conjugated magnetite nanoparticulates (MNPs) promote apoptosis in human lung cancer A549 cells. Biol. Inorg. Chem. 2020, 25, 13–22. [CrossRef]
- Izadpanah, M.R.; Salehzadeh, A.; Zaefizadeh, M.; Nikpasand, M. Functionalisation of Fe3O4 nanoparticles by 2-((pyrazol-4-yl)methylene)hydrazinecarbothioamide enhances the apoptosis of human breast cancer MCF-7 cells. IET Nanobiotechnol. 2020, 14, 508–518. [CrossRef]
- Shakya, B.; Yadav, P.N. Thiosemicarbazones as Potent Anticancer Agents and their Modes of Action. Mini-Rev. Med. Chem. 2020, 20, 638–661. [CrossRef]
- Richardson, D.R.; Sharpe, P.C.; Lovejoy, D.B.; Senaratne, D.; Kalinowski, D.S.; Islam, M.; Bernhardt, P.V. Dipyridyl Thiosemicarbazone Chelators with Potent and Selective Antitumor Activity Form Iron Complexes with Redox Activity. J. Med. Chem. 2006, 49 (22), 6510–6521. [CrossRef]
- Yu, Y.; Kalinowski, D.S.; Kovacevic, Z.; Siafakas, A.R.; Jansson, P.J.; Stefani, C.; Lovejoy, D.B.; Sharpe, P.C.; Bernhardt, P.V.; Richardson, D.R. Thiosemicarbazones from the Old to New: Iron Chelators That Are More Than Just Ribonucleotide Reductase Inhibitors. J. Med. Chem. 2009, 52, 5271–5294. [CrossRef]
- Jansson, P.J.; Sharpe, P.C.; Bernhardt, P.V.; Richardson, D.R. Novel Thiosemicarbazones of the ApT and DpT Series and Their Copper Complexes: Identification of Pronounced Redox Activity and Characterization of Their Antitumor Activity. J. Med. Chem. 2010, 53, 5759–5769. [CrossRef]
- Kate, A.N.; Kumbhar, A.A.; Khan, A.A.; Joshi, P.V.; Puranik, V.G. Monitoring Cellular Uptake and Cytotoxicity of Copper(II) Complex Using a Fluorescent Anthracene Thiosemicarbazone Ligand. Bioconjugate Chem. 2014, 25 (1), 102–114. [CrossRef]
- Reimers, J.R.; Ford, M.J.; Marcuccio, S.M.; Ulstrup, J.; Hush, N.S. Competition of van der Waals and chemical forces on gold–sulfur surfaces and nanoparticles. Nat. Rev. Chem. 2017, 1, 0017. [CrossRef]
- Patra, M.; Johnstone, T.C.; Suntharalingam, K.; Lippard, S.J. A Potent Glucose–Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells. Angew. Chem., Int. Ed. 2016, 55, 2550–2554. [CrossRef]
- Tekade, R.K.; Sun, X. The Warburg effect and glucose-derived cancer theranostics. Drug Discov. Today 2017, 22, 1637–1653. [CrossRef]
- Fadaka, A.; Ajiboye, B.; Ojo, O.; Adewale, O.; Olayide, I.; Emuowhochere, R. Biology of glucose metabolization in cancer cells. J. Oncol. Sci. 2017, 3, 45–51. [CrossRef]
- Toan, V.N.; Thanh, N.D.; Tri, N.M.; Huong, N.T.T. Synthesis and biological screening of thiosemicarbazones of substituted 3-acetylcoumarins having D-glucose moiety. Bioorg. Med. Chem. Lett. 2020, 30, 127664. [CrossRef]
- Zhang, Q.; Shao, J.; Wang, J.; Gong, X.-J.; Liu, W.-X.; Wang, S.; Zhang, Y.; Yang, S.; Zhang, Q.-S.; Wie, J.-X.; Tian, J.-L. Antitumor effects of new glycoconjugated PtII agents dual-targeting GLUT1 and Pgp proteins. Dalton Trans. 2022, 51, 16082. [CrossRef]
- Bisceglie, F.; Tavone, M.; Mussi, F.; Azzoni, S.; Montalbano, S.; Franzoni, S.; Tarasconi, P.; Buschini, A.; Pelosi, G. Effects of polar substituents on the biological activity of thiosemicarbazone metal complexes. J. Inorg. Biochem. 2018, 79, 60–70. [CrossRef]
- Thanh, N.D.; Giang, N.T.K.; Quyen, T.H.; Huong, D.T.; Toan, V.N. Synthesis and evaluation of in vivo antioxidant, in vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones. Eur. J. Med. Chem. 2016, 123, 532–543. [CrossRef]
- Ghosh, S.; Misra, A.K.; Bhatia, G.; Khan, M.M.; Khanna, A.K. Syntheses and evaluation of glucosyl aryl thiosemicarbazide and glucosyl thiosemicarbazone derivatives as antioxidant and anti-dyslipidemic agents. Bioorg. Med. Chem. Lett. 2009, 19, 386–389. [CrossRef]
- Tenchiu, A.-C.; Kostas, I.D.; Kovala-Demertzi, D.; Terzis, A. Synthesis and characterization of new aromatic aldehyde/ketone 4-(β-d-glucopyranosyl)thiosemicarbazones. Carbohydr. Res. 2009, 344 (11), 1352–1364. [CrossRef]
- Shultz, M.D.; Reveles, J.U.; Khanna, S.N.; Carpenter, E.E. Reactive Nature of Dopamine as a Surface Functionalization Agent in Iron Oxide Nanoparticles. J. Am. Chem. Soc. 2007, 129 (9), 2482–2487. [CrossRef]
- Ilyas, S.; Ullah, N.K.; Ilyas, M.; Wennhold, K.; Iqbal, M.; Schlößer, H.A.; Hussain, M.S.; Mathur, S. Mediating the Fate of Cancer Cell Uptake: Dual-Targeted Magnetic Nanovectors with Biotin and Folate Surface Ligands. ACS Biomater. Sci. Eng. 2020, 6 (11), 6138–6147. [CrossRef]
- Akao, A.; Nonoyama, N.; Yasuda, N. A mild and practical deprotection method for benzyl thioethers. Tetrahedron Lett. 2006, 47, 5337–5340. [CrossRef]
- Meldal, M.; Tornøe, C.W. Cu-Catalyzed Azide−Alkyne Cycloaddition. Chem. Rev. 2008, 108 (8), 2952–3015. [CrossRef]
- Agard, N.J.; Prescher, J.A.; Bertozzi, C.R. A Strain-Promoted [3 + 2] Azide−Alkyne Cycloaddition for Covalent Modification of Biomolecules in Living Systems. J. Am. Chem. Soc. 2004, 126 (46), 15046–15047. [CrossRef]
- Kolb, H.C.; Finn, M.G.; Sharpless K.B. Click Chemistry: Diverse Chemical Function from a Few Good Reactions. Angew. Chem. Int. Ed. 2001, 40, 2004–2021. [CrossRef]
- Tajima, H.; Li, G. Synthesis of Hydroxyalkyl Isothiocyanates. Synlett 1997, 7, 773–774. [CrossRef]
- Viart, H.M.; Larsen, T.S.; Tassone, C.; Andresen, T.L.; Clausen, M.H. Propargylamine–isothiocyanate reaction: efficient conjugation chemistry in aqueous media. Chem. Commun. 2014, 50, 7800–7802. [CrossRef]
- Arshadi, S.; Vessally, E.; Edjlali, L.; Hosseinzadeh-Khanmiri, R.; Ghorbani-Kalhor, E. N-Propargylamines: versatile building blocks in the construction of thiazole cores. Beilstein J. Org. Chem. 2017, 13, 625–638. [CrossRef]
- Mohammadnezhad, G.; Amirian, A. M.; Görls, H.; Plass, W.; Sandleben, A.; Schäfer, S.; Klein, A. Redox Instability of Copper(II) Complexes of a Triazine-Based PNP Pincer. Eur. J. Inorg. Chem. 2021, 2021, 1140–1151. [CrossRef]
- Das, M.; Mishra, D.; Dhak, P.; Gupta, S.; Maiti, T.K.; Basak, A.; Pramanik, P. Biofunctionalized, Phosphonate-Grafted, Ultrasmall Iron Oxide Nanoparticles for Combined Targeted Cancer Therapy and Multimodal Imaging. Small 2009, 5 (24), 2883–2893. [CrossRef]
- De Rosales, R.T.M.; Tavaré, R.; Glaria, A.; Varma, G.; Protti, A.; Blower, P.J. 99mTc-Bisphosphonate-Iron Oxide Nanoparticle Conjugates for Dual-Modality Biomedical Imaging. Bioconjugate Chem. 2011, 22 (3), 455–465. [CrossRef]
- Wu, W.; He, Q.; Jiang, C. Magnetic Iron Oxide Nanoparticles: Synthesis and Surface Functionalization Strategies. Nanoscale Res. Lett. 2008, 3, 397. [CrossRef]
- Lee, C. H.; Park, S. H.; Chung, W.; Kim, J. Y.; Kim, S. H. Preparation and characterization of surface modified silica nanoparticles with organo-silane compounds. Colloids Surf. A: Physicochem. Eng. Asp., 2011, 384 (1-3), 218–322. [CrossRef]






















Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).